Sylvie Trottier

6.6k total citations · 1 hit paper
63 papers, 2.0k citations indexed

About

Sylvie Trottier is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Sylvie Trottier has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 28 papers in Epidemiology and 9 papers in Microbiology. Recurrent topics in Sylvie Trottier's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (8 papers) and Reproductive tract infections research (7 papers). Sylvie Trottier is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (8 papers) and Reproductive tract infections research (7 papers). Sylvie Trottier collaborates with scholars based in Canada, United States and Burkina Faso. Sylvie Trottier's co-authors include Agnès Rode, Nelson Kinnersley, Penelope Ward, F. Y. Aoki, Michel G. Bergeron, Yves Longtin, Bianka Paquet-Bolduc, Jean Longtin, Christophe Garenc and José Côté and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sylvie Trottier

60 papers receiving 1.9k citations

Hit Papers

Efficacy and safety of oseltamivir in treatment of acute ... 2000 2026 2008 2017 2000 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
    2000 606 citations Sylvie Trottier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Trottier Canada 20 1.3k 942 223 205 149 63 2.0k
Klaris Riesenberg Israel 26 878 0.7× 535 0.6× 260 1.2× 192 0.9× 123 0.8× 89 2.6k
Glenn Wortmann United States 30 1.1k 0.8× 718 0.8× 232 1.0× 268 1.3× 114 0.8× 88 2.7k
Yu‐Chung Chuang Taiwan 27 1.0k 0.8× 909 1.0× 341 1.5× 119 0.6× 93 0.6× 122 2.3k
Peter T. Frame United States 28 1.6k 1.3× 1.4k 1.5× 149 0.7× 345 1.7× 255 1.7× 44 2.6k
Hyun‐Ha Chang South Korea 30 768 0.6× 924 1.0× 224 1.0× 66 0.3× 145 1.0× 117 2.4k
Francisc Schlaeffer Israel 24 735 0.6× 429 0.5× 197 0.9× 163 0.8× 125 0.8× 80 2.0k
Jack Lévy Belgium 23 568 0.4× 586 0.6× 149 0.7× 225 1.1× 59 0.4× 55 1.7k
Tahaniyat Lalani United States 21 750 0.6× 884 0.9× 159 0.7× 200 1.0× 55 0.4× 88 1.6k
José Bordón United States 24 1.3k 1.0× 376 0.4× 161 0.7× 63 0.3× 196 1.3× 69 2.1k
Gregory Filice United States 28 994 0.8× 606 0.6× 145 0.7× 60 0.3× 123 0.8× 68 2.3k

Countries citing papers authored by Sylvie Trottier

Since Specialization
Citations

This map shows the geographic impact of Sylvie Trottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Trottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Trottier more than expected).

Fields of papers citing papers by Sylvie Trottier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Trottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Trottier. The network helps show where Sylvie Trottier may publish in the future.

Co-authorship network of co-authors of Sylvie Trottier

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Trottier. A scholar is included among the top collaborators of Sylvie Trottier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Trottier. Sylvie Trottier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thériault, Mathieu, et al.. (2025). Assessment of Cross-Reactive Neutralizing Antibodies Induction Against H5N1 Clade 2.3.4.4b by Prior Seasonal Influenza Immunization in Retail Workers. Open Forum Infectious Diseases. 12(8). ofaf463–ofaf463. 2 indexed citations
2.
Bérubé, Ève, Martin Gagnon, Cindy Lalancette, et al.. (2025). Development of a PCR Assay for the Detection of Legionella micdadei in the Environment. Infectious Disease Reports. 17(5). 131–131.
3.
Stuible, Matthew, Yves Durocher, Mathieu Thériault, et al.. (2024). Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasets. PLoS ONE. 19(12). e0314499–e0314499. 1 indexed citations
4.
Cayer, Marie‐Pierre, Matthew Stuible, Christian Gervais, et al.. (2023). Assessment of the longitudinal humoral response in non-hospitalized SARS-CoV-2-positive individuals at decentralized sites: Outcomes and concordance. Frontiers in Immunology. 13. 1052424–1052424. 2 indexed citations
5.
Walmsley, Sharon, Terry Lee, Joel Singer, et al.. (2022). BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal Period. AIDS Research and Human Retroviruses. 39(4). 204–210. 6 indexed citations
6.
Andrew, Melissa K., Judith Godin, Jason J. LeBlanc, et al.. (2022). Older Age and Frailty are Associated with Higher Mortality but Lower ICU Admission with COVID-19. Canadian Geriatrics Journal. 25(2). 183–196. 4 indexed citations
7.
8.
Stuible, Matthew, Christian Gervais, Yves Durocher, et al.. (2021). Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins. Scientific Reports. 11(1). 21601–21601. 16 indexed citations
9.
McClymont, Elisabeth, Gina Ogilvie, Arianne Albert, et al.. (2020). Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV. Vaccine. 38(15). 3073–3078. 3 indexed citations
10.
Paquet-Bolduc, Bianka, Christophe Garenc, Philippe Gervais, et al.. (2017). Impact of Isolating Clostridium difficile Carriers on the Burden of Isolation Precautions: A Time Series Analysis. Clinical Infectious Diseases. 66(9). 1377–1382. 6 indexed citations
11.
Omar, Rabeea F., Édith Guilbert, Maria F Gallo, et al.. (2017). Empowerment of Women: Closing the Medical Technologies Gender Gap. Journal of Obstetrics and Gynaecology Canada. 40(1). 78–83. 2 indexed citations
12.
Longtin, Yves, Sylvie Trottier, Bianka Paquet-Bolduc, et al.. (2012). Impact of the Type of Diagnostic Assay on Clostridium difficile Infection and Complication Rates in a Mandatory Reporting Program. Clinical Infectious Diseases. 56(1). 67–73. 183 indexed citations
13.
Mbopi‐Kéou, François‐Xavier, Sylvie Trottier, Rabeea F. Omar, et al.. (2009). A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom® formulations in women from Cameroon. Contraception. 80(5). 484–492. 11 indexed citations
14.
Romanowski, Barbara, et al.. (2009). Seroprevalence and Risk Factors for Herpes Simplex Virus Infection in a Population of HIV-Infected Patients in Canada. Sexually Transmitted Diseases. 36(3). 165–169. 22 indexed citations
15.
Mbopi‐Kéou, François‐Xavier, Sylvie Trottier, Rabeea F. Omar, et al.. (2009). A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom® formulations in Cameroonian women. Contraception. 81(1). 79–85. 21 indexed citations
16.
Bodsworth, Neil, Mark Bloch, Anna McNulty, et al.. (2008). 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study. Sexual Health. 5(3). 219–219. 17 indexed citations
17.
18.
19.
Leone, Peter A., et al.. (2002). Valacyclovir for Episodic Treatment of Genital Herpes: A Shorter 3‐Day Treatment Course Compared with 5‐Day Treatment. Clinical Infectious Diseases. 34(7). 958–962. 58 indexed citations
20.
Bergeron, Michel G., et al.. (1982). Disturbed Intrarenal Distribution of Gentamicin in Experimental Pyelonephritis Due to Escherichia coli. The Journal of Infectious Diseases. 146(3). 436–439. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaris Riesenberg Breakdown of academic impact, for papers by Glenn Wortmann Breakdown of academic impact, for papers by Yu‐Chung Chuang Breakdown of academic impact, for papers by Peter T. Frame Breakdown of academic impact, for papers by Hyun‐Ha Chang Breakdown of academic impact, for papers by Francisc Schlaeffer Breakdown of academic impact, for papers by Jack Lévy Breakdown of academic impact, for papers by Tahaniyat Lalani Breakdown of academic impact, for papers by José Bordón Breakdown of academic impact, for papers by Gregory Filice
Rankless by CCL
2026